Is Hims & Hers Health Stock a Buy? [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
The stock took a bit of a hit as a result Then the company released first-quarter earnings amid the uproar, giving bulls a lot to cheer about. While it's often a bad idea for a company to go anywhere near political discussions, there are enough reasons the business is doing well to help overcome its recent stumble and become an excellent long-term investment. Here are six potential reasons to buy Hims & Hers stock today. 1. Hims & Hers continues to innovate its product lineup Hims & Hers is a telehealth company that lets patients digitally consult with professional care providers and have any prescribed treatments shipped to the patients' homes. It's not a unique business model, but the company's stellar execution has driven success even as potential non-traditional healthcare competitors like Walmart have tried and later abandoned their ventures. Healthcare is so flexible that it unlocks many product innovation opportunities for management. In its latest report, Hims & Hers
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $17.25 to $22.00. They now have a "buy" rating on the stock.MarketBeat
- Hims & Hers Health Stock Soared This Week: Here's Why [Yahoo! Finance]Yahoo! Finance
- The Ultimate Growth Stock to Buy With $20 Right Now [Yahoo! Finance]Yahoo! Finance
- Reasons to Include Alcon (ALC) in Your Portfolio Right Now [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $20.00 to $24.00. They now have a "buy" rating on the stock.MarketBeat
HIMS
Earnings
- 5/6/24 - Beat
HIMS
Sec Filings
- 6/10/24 - Form 8-K
- 6/10/24 - Form 4
- 6/10/24 - Form 4
- HIMS's page on the SEC website